{
    "id": 6431,
    "fullName": "TGFBR2 R537P",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "TGFBR2 R537P lies within the protein kinase domain of the Tgfbr2 protein (UniProt.org). R537P results in constitutive activation of Tgfbr2 kinase activity, downstream activation of Smad1/5, and increased metastasis in cancer cells (PMID: 18339844).",
            "references": [
                {
                    "id": 2767,
                    "pubMedId": 18339844,
                    "title": "Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18339844"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7048,
        "geneSymbol": "TGFBR2",
        "terms": [
            "TGFBR2",
            "AAT3",
            "FAA3",
            "LDS1B",
            "LDS2",
            "LDS2B",
            "MFS2",
            "RIIC",
            "TAAD2",
            "TBR-ii",
            "TBRII",
            "TGFbeta-RII",
            "TGFR-2"
        ]
    },
    "variant": "R537P",
    "createDate": "05/19/2015",
    "updateDate": "05/21/2015",
    "referenceTranscriptCoordinates": {
        "id": 130919,
        "transcript": "NM_003242",
        "gDna": "chr3:g.30691505G>C",
        "cDna": "c.1610G>C",
        "protein": "p.R537P",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2207,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY2109761 induced an epithelioid phenotype and inhibited migration of HNSCC cells expressing TGFBR2 R537P (PMID: 18339844).",
            "molecularProfile": {
                "id": 6281,
                "profileName": "TGFBR2 R537P"
            },
            "therapy": {
                "id": 2711,
                "therapyName": "LY2109761",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2767,
                    "pubMedId": 18339844,
                    "title": "Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18339844"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 6281,
            "profileName": "TGFBR2 R537P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 130920,
            "transcript": "XM_011534043",
            "gDna": "chr3:g.30691478G>C",
            "cDna": "c.1610G>C",
            "protein": "p.R537P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 130919,
            "transcript": "NM_003242",
            "gDna": "chr3:g.30691505G>C",
            "cDna": "c.1610G>C",
            "protein": "p.R537P",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}